Company / EPS (Diluted)
Zimmer Biomet EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$4.88
FY2025
5-year range
-$0.67 / $5.47
FY2021-FY2025
Trend
+343.6%
vs FY2024
Sector context
#36 of 159
Health Care
What the data says
EPS (Diluted) changed +344% YoY in FY2025, a notable deviation from the 9-year average annual change of +150%.
Based on SEC 10-K filings.
4.88 in FY2025. Top quartile in the Health Care sector.
Improved from $1.91 to $4.88 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 159This company $4.88 Sector average $1.56
▼
+213.5% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 343.6% year-over-year.
- Ranks #36 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.88 | +343.6% |
| FY2024 | $1.10 | -42.4% |
| FY2023 | $1.91 | +385.1% |
| FY2022 | -$0.67 | -112.2% |
| FY2021 | $5.47 | +394.1% |
| FY2020 | -$1.86 | -120.9% |
| FY2019 | $8.90 | +489.4% |
| FY2018 | $1.51 | +96.1% |
| FY2017 | $0.77 | -81.7% |
| FY2016 | $4.20 | -7.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026